🔎 Trials Near Me

Home › NCT06396897

Hospital @ Home Model of Care for Cirrhosis

Recruiting

The Hospital @ Home Model of Care: A Novel Healthcare Solution for the Management of Decompensated Cirrhosis

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Enrolled into IUH's H@H program
* At least 18 years of age
* Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
* English speaking
* Able to provide consent
* Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
* Able to perform activities of daily living independently
* Lives within IU Health Home service area

Exclusion Criteria:

* Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
* Transplant of organ other than liver
* Pregnant
* Incarcerated
* New hemodialysis
* Blood pressure \< 90/60, Pulse \> 120, O2 \> 6L or \>2L above baseline
* HIV+/CD4 count \< 200
* Receiving hospice services
* Concurrent enrollment in a related research study

About the study

The purpose of this study is to work with patients diagnosed with end-stage liver disease to understand their perspectives on the Health at Home (H@H) Program, including desired outcomes and expectations, perceived barriers, and drivers. H@H is an emerging model of home-based care, designed to extend traditional, inpatient hospital care which may address these needs. Through H@H, acute medical care services as well as ancillary care such as rehabilitation therapy can be delivered in the home. The study is divided into three phases: Phase 1 occurs while the participant is an inpatient. Phase 2 is when the actual H@H program takes place as part of the participant's clinical care. The study team will not be involved in the Phase 2 - H@H program as it will be conducted by the clinical staff. Phase 3, at which point the participant enters a rehabilitation phase to transition the patient to self-management, involves a research jam session with the participant and caregiver to assess the value of the program.

What is being tested

Sponsor: Indiana University · Participants: 30 · Started: May 10, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06396897

Locations in the U.S.

IndianaIU School of Medicine, Indianapolis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.